DK286090A - Alfa-adrenerge receptorantagonister - Google Patents

Alfa-adrenerge receptorantagonister Download PDF

Info

Publication number
DK286090A
DK286090A DK286090A DK286090A DK286090A DK 286090 A DK286090 A DK 286090A DK 286090 A DK286090 A DK 286090A DK 286090 A DK286090 A DK 286090A DK 286090 A DK286090 A DK 286090A
Authority
DK
Denmark
Prior art keywords
adrenerge
alfa
receptor antagonists
antagonists
adrenoceptor
Prior art date
Application number
DK286090A
Other languages
English (en)
Other versions
DK286090D0 (da
Inventor
John Joseph Lafferty
Robert Michael Demarinis
Dinubhai Himatlal Shah
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK286090A publication Critical patent/DK286090A/da
Publication of DK286090D0 publication Critical patent/DK286090D0/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
DK286090A 1988-06-01 1990-11-30 Alfa-adrenerge receptorantagonister DK286090D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20100588A 1988-06-01 1988-06-01
PCT/US1989/002395 WO1989012053A1 (en) 1988-06-01 1989-05-31 alpha-ADRENERGIC RECEPTOR ANTAGONISTS

Publications (2)

Publication Number Publication Date
DK286090A true DK286090A (da) 1990-11-30
DK286090D0 DK286090D0 (da) 1990-11-30

Family

ID=22744089

Family Applications (1)

Application Number Title Priority Date Filing Date
DK286090A DK286090D0 (da) 1988-06-01 1990-11-30 Alfa-adrenerge receptorantagonister

Country Status (19)

Country Link
EP (1) EP0344981B1 (da)
JP (1) JP2846019B2 (da)
KR (1) KR900701796A (da)
CN (1) CN1029404C (da)
AT (1) ATE109483T1 (da)
AU (1) AU629221B2 (da)
CA (1) CA1320954C (da)
DE (1) DE68917217T2 (da)
DK (1) DK286090D0 (da)
ES (1) ES2057121T3 (da)
FI (1) FI905922A0 (da)
HU (1) HU208695B (da)
IE (1) IE66886B1 (da)
MY (1) MY106292A (da)
PH (1) PH25534A (da)
PT (1) PT90720B (da)
WO (1) WO1989012053A1 (da)
ZA (1) ZA894099B (da)
ZW (1) ZW6989A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2824106B1 (en) * 2012-03-06 2016-11-23 Takeda Pharmaceutical Company Limited Tricyclic compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856910A (en) * 1950-01-10 1974-12-24 Roussel Uclaf Novel thienobenzazepines as anti-depressants
US3649644A (en) * 1969-08-08 1972-03-14 Warner Lambert Co 1 2 3 4 4a 5 6 6a-octahydrobenzofuro (3 2-c)indoles
BE795451A (fr) * 1972-02-23 1973-08-16 Pfizer Agents hypoglycemiants aza indoliques tricycliques
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
JPS57144286A (en) * 1981-03-02 1982-09-06 Takeda Chem Ind Ltd Azepinoindole derivative and its preparation
US4833244A (en) * 1985-04-22 1989-05-23 Hoechst-Rouseel Pharmaceuticals Inc. Ethanobenzazepines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4769368A (en) * 1986-02-10 1988-09-06 Smithkline Beckman Corporation 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines
DE3630539A1 (de) * 1986-09-08 1988-03-10 Madaus & Co Dr Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten

Also Published As

Publication number Publication date
FI905922A0 (fi) 1990-11-30
PT90720B (pt) 1994-10-31
HU893309D0 (en) 1991-05-28
PH25534A (en) 1991-07-24
EP0344981A3 (en) 1991-05-15
CA1320954C (en) 1993-08-03
WO1989012053A1 (en) 1989-12-14
JPH03504604A (ja) 1991-10-09
ZA894099B (en) 1990-06-27
DE68917217D1 (de) 1994-09-08
AU629221B2 (en) 1992-10-01
MY106292A (en) 1995-04-29
IE891740L (en) 1989-12-01
JP2846019B2 (ja) 1999-01-13
HUT58742A (en) 1992-03-30
DK286090D0 (da) 1990-11-30
IE66886B1 (en) 1996-02-07
HU208695B (en) 1993-12-28
CN1029404C (zh) 1995-08-02
EP0344981B1 (en) 1994-08-03
ATE109483T1 (de) 1994-08-15
DE68917217T2 (de) 1994-12-01
EP0344981A2 (en) 1989-12-06
KR900701796A (ko) 1990-12-04
ES2057121T3 (es) 1994-10-16
CN1038100A (zh) 1989-12-20
PT90720A (pt) 1989-12-29
ZW6989A1 (en) 1989-08-30
AU3741589A (en) 1990-01-05

Similar Documents

Publication Publication Date Title
DE69034103D1 (de) Imidazoalkensäure
SE8505112D0 (sv) Novel pharmacological compounds
FI905481A0 (fi) Substituerade n-(imidazolyl) -alkylalaninderivat.
FI881609A0 (fi) Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE113949T1 (de) Alpha-adrenergische rezeptorantagonisten.
ATE114310T1 (de) Alpha-adrenergische rezeptorantagonisten.
DK286090D0 (da) Alfa-adrenerge receptorantagonister
ATE79540T1 (de) Pharmazeutische zusammensetzung.
EP0344980A3 (en) Alpha-adrenergic receptor antagonists
FI873145A (fi) Nya tetracykliska indolderivat.
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment